These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 37329237)
1. Kidney outcomes and prognostic factors of myeloma associated acute kidney injury in the contemporary era. Ratnayake C; Gibbs SDJ; Lee D Nephrology (Carlton); 2023 Oct; 28(10):561-566. PubMed ID: 37329237 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients. Ecotière L; Thierry A; Debiais-Delpech C; Chevret S; Javaugue V; Desport E; Belmouaz S; Quellard N; Kaaki S; Goujon JM; Fermand JP; Touchard G; Bridoux F Nephrol Dial Transplant; 2016 Jan; 31(1):64-72. PubMed ID: 26289418 [TBL] [Abstract][Full Text] [Related]
3. Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury. Yadav P; Hutchison CA; Basnayake K; Stringer S; Jesky M; Fifer L; Snell K; Pinney J; Drayson MT; Cook M; Cockwell P Eur J Haematol; 2016 Jun; 96(6):610-7. PubMed ID: 26248588 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study. Sens F; Chaintreuil D; Jolivot A; Guebre-Egziabher F; Robinson P; Karlin L; Bridoux F; Juillard L Am J Nephrol; 2017; 46(5):355-363. PubMed ID: 29017155 [TBL] [Abstract][Full Text] [Related]
5. Severe acute kidney injury and multiple myeloma: evaluation of kidney and patient prognostic factors. Rodrigues L; Neves M; Sá H; Gomes H; Pratas J; Campos M Eur J Intern Med; 2014 Sep; 25(7):652-6. PubMed ID: 25034390 [TBL] [Abstract][Full Text] [Related]
6. Continued monitoring of acute kidney injury survivors might not be necessary in those regaining an estimated glomerular filtration rate >60 mL/min at 1 year. Stoumpos S; Mark PB; McQuarrie EP; Traynor JP; Geddes CC Nephrol Dial Transplant; 2017 Jan; 32(1):81-88. PubMed ID: 28391314 [TBL] [Abstract][Full Text] [Related]
7. [Expert consensus for the diagnosis and treatment of patients with renal impairment of multiple myeloma]. Renal Impairment of Multiple Myeloma Collaborative Study Group Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):871-875. PubMed ID: 29136724 [TBL] [Abstract][Full Text] [Related]
8. Management of acute kidney injury in symptomatic multiple myeloma. Bridoux F; Leung N; Belmouaz M; Royal V; Ronco P; Nasr SH; Fermand JP; Kidney Int; 2021 Mar; 99(3):570-580. PubMed ID: 33440212 [TBL] [Abstract][Full Text] [Related]
9. [Morphological and immunohistochemical predictors of renal response to therapy patients with myeloma cast nephropathy and dialysis-dependent acute kidney injury]. Rekhtina IG; Kazarina EV; Stolyarevich ES; Kovrigina AM; Dvirnyk VN; Kulikov SM; Mendeleeva LP Ter Arkh; 2020 Sep; 92(7):63-69. PubMed ID: 33346446 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapy plus therapeutic plasmapheresis with 4% human albumin solution in multiple myeloma patients with acute kidney injury: a prospective, open-label, proof-of-concept study. Wu T; Liu D; Liu S; Xiao H; Xiong B; Zhou Y; Xiong Y; Cui Q; Wu J; Liu M; Liu H; Li Y; Wang M; Bao X; Li Y; Zhou F Ren Fail; 2024 Dec; 46(1):2356708. PubMed ID: 38803220 [TBL] [Abstract][Full Text] [Related]
11. Serum free light chain level at diagnosis in myeloma cast nephropathy-a multicentre study. Yadav P; Sathick IJ; Leung N; Brown EE; Cook M; Sanders PW; Cockwell P Blood Cancer J; 2020 Mar; 10(3):28. PubMed ID: 32127527 [TBL] [Abstract][Full Text] [Related]
13. Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion. Murgia S; Quattrocchio G; Forneris G; Pozzato M; Fenoglio R; Ferro M; De Simone E; Del Vecchio G; Di Benedetto C; Roccatello D J Nephrol; 2022 May; 35(4):1243-1249. PubMed ID: 34982413 [TBL] [Abstract][Full Text] [Related]
16. Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: A case report. Donati G; Zappulo F; Croci Chiocchini AL; Comai G; Zamagni E; La Manna G Hemodial Int; 2019 Jul; 23(3):E97-E99. PubMed ID: 30791209 [TBL] [Abstract][Full Text] [Related]
17. Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology. Fabbrini P; Finkel K; Gallieni M; Capasso G; Cavo M; Santoro A; Pasquali S J Nephrol; 2016 Dec; 29(6):735-746. PubMed ID: 27757797 [TBL] [Abstract][Full Text] [Related]
18. Survival after acute kidney injury requiring dialysis: long-term follow up. Duran PA; Concepcion LA Hemodial Int; 2014 Oct; 18 Suppl 1():S1-6. PubMed ID: 25330825 [TBL] [Abstract][Full Text] [Related]
19. Response and Dynamics of Renal Function in Transplantation-Eligible Multiple Myeloma Patients Treated with a Novel Agent: The CAREMM-2201 Study. Kim Y; Park SS; Jeon YW; Yahng SA; Shin SH; Min CK; Transplant Cell Ther; 2023 Jan; 29(1):55.e1-55.e9. PubMed ID: 36202336 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of renal function in elderly patients with acute kidney injury. Li Q; Zhao M; Du J; Wang X Clin Interv Aging; 2017; 12():153-160. PubMed ID: 28176909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]